# Acepodia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/acepodia

- Industry: Biotechnology
- Headquarters: Alameda, US
- Website: www.acepodia.com
- Total disclosed funding: $256M
- Latest round: Series D (Jun 6, 2023)
- Investors on record: 8

## About

Based in California, US, and founded in 2016 by CEO Dr. Sonny Hsiao and co-founder Dr. Patrick Y. Yang, Acepodia Inc. operates as a biotechnology company that develops allogeneic cell therapies for the treatment of cancer. The company also has an office in Taiwan. In June 2023, Acepodia Inc. raised USD 100 million in series D funding led by Digital Mobile Venture.

Acepodia Inc. develops allogeneic cell therapies with Antibody-Cell Conjugation (ACC) platform technology to address gaps in cancer care. The company links tumor-targeting antibodies to its proprietary immune cells, such as gamma delta T cells and off-the-shelf natural killer (NK) cells, to create novel antibody cell effector (ACE) therapies.

Acepodia Inc. plans to use the June 2023 funding to support the development of its oncology pipeline such as ACE1831 and ACE2016.

## Funding rounds

- Series D, Jun 6, 2023, $100M — Digital Mobile Venture
- Series C, Dec 2, 2021, $109M — CDIB Capital Group, DEFTA Partners, E. Sun Financial, Ridgeback Capital Management, 8VC, BioEngine Venture Capital, PerforMax Global, Digital Mobile Venture
- Series B, Mar 16, 2021, $47M — CDIB Capital Group, DEFTA Partners, Ridgeback Capital Management, 8VC

## Investors

- CDIB Capital Group (https://capitalatlas.ai/funds/cdib-capital-group) — Series B, Series C
- DEFTA Partners (https://capitalatlas.ai/funds/defta-partners) — Series B, Series C
- Ridgeback Capital Management — Series B, Series C
- 8VC (https://capitalatlas.ai/funds/8vc) — Series B, Series C
- E. Sun Financial — Series C
- BioEngine Venture Capital (https://capitalatlas.ai/funds/bioengine-venture-capital) — Series C
- PerforMax Global — Series C
- Digital Mobile Venture (https://capitalatlas.ai/funds/digital-mobile-venture) — Series C, Series D